Hims & Hers Health Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Hims & Hers Health hat ein Gesamteigenkapital von $440.1M und eine Gesamtverschuldung von $0.0, wodurch sich der Verschuldungsgrad auf 0% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen $602.3M bzw. $162.2M. Hims & Hers Health Das EBIT des Unternehmens beträgt $46.0M, so dass der Zinsdeckungsgrad -4.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von $254.1M.

Wichtige Informationen

0%

Verhältnis von Schulden zu Eigenkapital

US$0

Verschuldung

Zinsdeckungsgrad-4.5x
BargeldUS$254.07m
EigenkapitalUS$440.05m
GesamtverbindlichkeitenUS$162.21m
GesamtvermögenUS$602.26m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Hims & Hers Health: The Amazon Curse Is Being Overstated

Nov 15

Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow

Nov 05

HIMS: GLP-1 Is Just The Beginning

Oct 17

Hims & Hers: Shortage Saga Brings Stupendous Risk-Reward

Oct 03

Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 25% Share Price Bounce

Oct 01
Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 25% Share Price Bounce

Hims & Hers Is Unbelievably Cheap And Profitable: Buy Now

Sep 24

Hims & Hers Health Post Q2 Earnings - Compounded GLP-1 Ploy Faces New Threats (Rating Downgrade)

Aug 27

Hims & Hers: Digesting Q2 2024 Earnings, Shares Still Undervalued, Rating Downgrade

Aug 20

Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Aug 11
Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Hims & Hers Health: Buy The Dip, With Or Without The GLP-1 Shortage

Aug 07

Hims & Hers: The Thesis Goes Far Beyond GLP-1

Jul 18

Hims & Hers: Buy The Dip To Catch The Next Rip

Jun 24

Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Jun 19
Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Hims & Hers: The Undervalued Gem Poised For Growth

Jun 18

Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable

Jun 10

Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

May 31
Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead

May 21

Hims & Hers Health: An Unforced Error

May 06

Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

May 04
Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry

Apr 24

Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation

Apr 05

Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock

Mar 21

Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health

Mar 12

Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Feb 28
Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Hims & Hers: Turning The Profitability Corner And Returning 28%

Feb 25

Hims & Hers Health: No Clear Moat Besides First Mover Advantage

Jan 23

Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple

Jan 10

Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Jan 07
Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Hims & Hers Health Q3: The Cheapest Growth Stock Around

Dec 14

Hims & Hers Health: What Would The Author Of 100 Baggers Say?

Nov 30

Hims & Hers: The Most Undervalued Small Cap Stock I See

Nov 08

Hims & Hers: A Promising Company With Resolvable Challenges

Nov 02

Hims & Hers: Specialization Is The Secret To Great Growth

Oct 25

Hims & Hers Health: Can't Get Much Better

Sep 25

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: HIMSDie kurzfristigen Aktiva des Unternehmens ($326.4M) übersteigen seine kurzfristigen Passiva ($152.6M).

Langfristige Verbindlichkeiten: HIMSDie kurzfristigen Vermögenswerte des Unternehmens ($326.4M) übersteigen seine langfristigen Verbindlichkeiten ($9.6M).


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: HIMS ist schuldenfrei.

Schulden abbauen: HIMS hat keine Schulden im Vergleich zu vor 5 Jahren, als das Verhältnis von Schulden zu Eigenkapital 8% betrug.

Schuldendeckung: HIMS hat keine Schulden und muss daher nicht durch den operativer Cashflow gedeckt werden.

Zinsdeckung: HIMS hat keine Schulden, daher ist die Deckung der Zinszahlungen kein Problem.


Bilanz


Entdecken Sie finanziell stabile Unternehmen